Vanda Pharmaceuticals (VNDA) Change in Inventory (2012 - 2026)
Vanda Pharmaceuticals (VNDA) reported Change in Inventory of -$294000.0 for Q1 2026, down 115.89% on a YoY basis from $1.8 million in Q1 2025, and down 122.97% sequentially from $1.3 million in Q4 2025.
Vanda Pharmaceuticals (VNDA) Change in Inventory (2012 - 2026) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 14 years of Change in Inventory data on file, last reported at -$294000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory fell 115.89% year-over-year to -$294000.0; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (down 30.71% YoY), and the FY2025 full-year result was $3.5 million, up 11851.72% from the prior year.
- Change in Inventory slipped to -$294000.0 in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $1.8 million in Q1 2025 to a low of -$294000.0 in Q1 2026.
- A 5-year average of $497117.6 and a median of $368000.0 in 2025 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory plunged 133.75% in 2023 and surged 6479.31% in 2025, its largest moves.
- Tracing VNDA's Change in Inventory over 5 years: stood at $1.1 million in 2022, then plunged by 62.21% to $427000.0 in 2023, then tumbled by 74.94% to $107000.0 in 2024, then jumped by 1096.26% to $1.3 million in 2025, then tumbled by 122.97% to -$294000.0 in 2026.
- Business Quant data shows VNDA's Change in Inventory at -$294000.0 in Q1 2026, $1.3 million in Q4 2025, and -$32000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn | -294,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -294,000.00 |
| Mar 31, 2026 | -294,000.00 |
| Dec 31, 2025 | 1.28 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | -32,000.00 |
| Sep 30, 2025 | -32,000.00 |
| Jun 30, 2025 | 368,000.00 |
| Jun 30, 2025 | 368,000.00 |
| Mar 31, 2025 | 1.85 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 107,000.00 |
| Dec 31, 2024 | 107,000.00 |
| Sep 30, 2024 | 214,000.00 |
| Sep 30, 2024 | 214,000.00 |
| Jun 30, 2024 | -263,000.00 |
| Jun 30, 2024 | -263,000.00 |
| Mar 31, 2024 | -29,000.00 |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | 427,000.00 |
| Dec 31, 2023 | 427,000.00 |